Basic Information
| LncRNA/CircRNA Name | B4GALT1-AS1 |
| Synonyms | NA |
| Region | GRCh38_9:33166975-33179983 |
| Ensemble | ENSG00000233554 |
| Refseq | NR_108108 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colon cancer |
| ICD-0-3 | C18 |
| Methods | RNA-seq |
| Sample | tissue |
| Expression Pattern | up-regulated |
| Function Description | Mechanistically, RNA-sequencing data found that the Hippo pathway in cancer was shown on pathways mostly upregulated by B4GALT1-AS1 knockdown, |
| Pubmed ID | 30912138 |
| Year | 2019 |
| Title | lncRNA B4GALT1-AS1 promotes colon cancer cell stemness and migration by recruiting YAP to the nucleus and enhancing YAP transcriptional activity. |
External Links
| Links for B4GALT1-AS1 | GenBank HGNC NONCODE |
| Links for colon cancer | OMIM COSMIC |